Compare HALO & PDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HALO | PDI |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 7.7B |
| IPO Year | N/A | N/A |
| Metric | HALO | PDI |
|---|---|---|
| Price | $63.51 | $18.10 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $73.33 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 1.5M |
| Earning Date | 11-03-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.81% |
| EPS Growth | ★ 56.68 | N/A |
| EPS | ★ 4.74 | N/A |
| Revenue | ★ $1,242,852,000.00 | N/A |
| Revenue This Year | $32.47 | N/A |
| Revenue Next Year | $24.31 | N/A |
| P/E Ratio | $13.37 | ★ N/A |
| Revenue Growth | ★ 31.19 | N/A |
| 52 Week Low | $46.26 | $15.45 |
| 52 Week High | $79.50 | $19.60 |
| Indicator | HALO | PDI |
|---|---|---|
| Relative Strength Index (RSI) | 33.96 | 46.86 |
| Support Level | $61.70 | $17.32 |
| Resistance Level | $74.25 | $18.12 |
| Average True Range (ATR) | 2.52 | 0.17 |
| MACD | -0.97 | 0.08 |
| Stochastic Oscillator | 13.39 | 88.95 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
PIMCO Dynamic Income Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek current income. Its secondary objective is to seek capital appreciation. The fund invests world-wide in a portfolio of debt obligations and other income-producing securities with varying maturities and related derivative instruments. Its investment portfolio includes mortgage-backed securities, investment-grade, and high-yield corporates, corporate and sovereign bonds, other income-producing securities, and related derivative instruments.